Logo
Logo

About Permethrin API

Product
  • Therapeutic CategoryAnti-Infective

  • CAS Number

    52645-53-1

  • API Technology

    Synthetic

  • Dose Form

    Lotion (Topical)

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, EUDMF, Korea DMF

Mechanism of Action

Permethrin acts on the nerve cell membrane to disrupt the sodium channel current by which the polarization of the membrane is regulated. Delayed repolarization and paralysis of the pests are the consequences of this disturbance.

Indication

For the treatment of infestation with Sarcoptes scabiei (scabies).

Related APIs

Ciprofloxacin Hydrochloride

Anti-Infective

arrow

Gatifloxacin (Anhydrous)

Anti-Infective

arrow

Levofloxacin Hemihydrate

Anti-Infective

arrow

Moxifloxacin Hydrochloride (Anhydrous)

Anti-Infective

arrow

Permethrin

Anti-Infective

arrow

Posaconazole

Anti-Infective

arrow

Terbinafine Hydrochloride

Anti-Infective

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.